Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
October 26, 2023 at 07:05 AM EDT
Bristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
